Cue Biopharma, Inc. · NASDAQ:CUE
Lin Shao-Lee sold 58,258 Cue Biopharma, Inc. shares (Form 4)
Traded Aug 12 to Aug 13, 2026 · Filed Aug 14, 2026
From Aug 12 to Aug 13, 2026, Lin Shao-Lee (Director, Chief Executive Officer) sold 58,258 Cue Biopharma, Inc. shares at an average US$27.58 for US$1.61M, leaving 705,995 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 58,258 shares
- Price
- US$27.58 average (US$26.99 to US$29.48)
- Value
- US$1.61M
- Holding after
- 705,995 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 109,179 | 764,253 | Direct | |
| Aug 12, 2026 | Common Stock | Sale | 34,225 | US$26.99 | 730,028 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 5,775 | US$27.75 | 724,253 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 5,423 | US$27.19 | 718,830 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 2,375 | US$28.11 | 716,455 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 10,460 | US$29.48 | 705,995 | Direct |
Source
Related
- Cue Biopharma, Inc.
- Lin Shao-Lee
- Cue Biopharma, Inc. shareholders
- Form 4 · Lin Shao-Lee · Oct 14, 2026
- Form 4 · Lin Shao-Lee · Jul 10, 2026
- Form 4 · Lin Shao-Lee · May 7, 2026
- Form 4 · Ray Sumita · Oct 14, 2026
- Form 4 · Meluzio Michael Vincent · Oct 14, 2026
- Schedule 13G/A · Mark E. Strome · Oct 8, 2026
- Form 4/A · Sarraf Pasha · Aug 28, 2026
- Form 4/A · Garzone Pamela · Aug 28, 2026